From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|4|6|667-675

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.6, 2005-12, pp. : 667-675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

Endocannabinoids in the Central Nervous System: From Neuronal Networks to Behavior

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Roles of Histamine in Autoimmune Demyelinating Disease of the Central Nervous System

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 6, 2011-12 ,pp. : 418-426

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?

By Di Marzo V.   Bifulco M.   De Petrocellis L.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 6, 2000-06 ,pp. : 195-197

Elsevier

Access to resources Recommend Favorite

Inflammation in the central nervous system in multiple sclerosis: The role of chemokines and their receptors

By Simpson Julie E.   Woodroofe M. Nicola  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 23-33

VSP

Access to resources Recommend Favorite